Nortem BioGroup Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2019	FY 2018	FY 2017
Period Ending	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	0.11	0.07	0.09
Short-Term Investments	0.07	0.07	0.11
Cash & Short-Term Investments	0.18	0.14	0.2
Cash Growth	29.29%	-30.96%	-
Accounts Receivable	0	0.1	0.01
Other Receivables	0.59	0.11	0.11
Receivables	0.59	0.21	0.11
Inventory	0.44	0.19	0.14
Prepaid Expenses	0.16	-	-
Other Current Assets	-	0	-
Total Current Assets	1.37	0.54	0.46
Property, Plant & Equipment	3.58	4.09	4.49
Long-Term Investments	0.36	0.36	0.36
Other Intangible Assets	1.29	1.19	0.96
Total Assets	6.6	6.19	6.26
Accounts Payable	0.35	0.08	0.22
Short-Term Debt	0.11	0.07	0.02
Other Current Liabilities	0.23	-0	-
Total Current Liabilities	0.7	0.15	0.25
Long-Term Debt	0.08	0.16	0.1
Other Long-Term Liabilities	2.45	2.99	3.06
Total Liabilities	3.23	3.3	3.41
Common Stock	3.2	2.8	2.8
Retained Earnings	0.14	0.09	0.04
Comprehensive Income & Other	0.03	0	0
Shareholders' Equity	3.37	2.89	2.85
Total Liabilities & Equity	6.6	6.19	6.26
Total Debt	0.19	0.23	0.13
Net Cash (Debt)	-0.01	-0.09	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.